iGlarLixi Reduces Glycated Hemoglobin to a Greater Extent Than Basal Insulin Regardless of Levels at Screening: Post Hoc Analysis of LixiLan-L
Crossref DOI link: https://doi.org/10.1007/s13300-017-0336-6
Published Online: 2017-11-16
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Niemoeller, Elisabeth
Souhami, Elisabeth
Wu, Yujun
Jensen, Klaus H.
Funding for this research was provided by:
Sanofi
Text and Data Mining valid from 2017-11-16
Article History
Received: 29 August 2017
First Online: 16 November 2017